Volume 21, Issue 15

Letters in Drug Design & Discovery - Volume 21, Issue 15, 2024

Volume 21, Issue 15, 2024

- In silico Exploration of the Therapeutic Potential of Alkaloids as Anti-infective Agents
  
  Authors: Nidhi Rani, Praveen Kumar, Aditya Walia and Randhir Singh
  
  https://doi.org/10.2174/0115701808276535231212071700
  More Less
  
  BackgroundAlkaloids are important phytoconstituents obtained from various plant sources.MethodsThe main objective of the study was to evaluate the anti-infective potential of alkaloids against 14α-demethylase, transpeptidase, and omicron spike protein using molecular docking studies. The potential constituents were identified and an ADMET study was performed.ResultsThe study concluded that reserpine and tubocurarine Read More
  
  Add to my favourites
  
  Email this

◄ 1 2

20 | 50 | 100 per page

Most Cited Most Cited RSS feed

- Discovery, Structural Determination and Anticancer Activities of Lactucinlike Guaianolides
  
  Authors: Yulin Ren, Yawei Zhou, Xiaozhuo Chen and Yunhua Ye
- Thermodynamic Aspects of Cancer: Possible Role of Negative Entropy in Tumor Growth, its Relation to Kinetic and Genetic Resistance
  
  Authors: Joseph Molnar, Barry S. Thornton, Annamaria Molnar, Dezso Gaal, Liaofu Luo and Elke S. Bergmann-Leitner
- Immunomodulatory Properties of Synthetic Imidazolone Derivatives
  
  Authors: M. A. Mesaik, K. M. Khan, S. Rahat, Zia-Ullah, M. I. Choudhary, S. Murad, N. R. Abdullah, Atta-ur-Rahman, A. Ahmad and R. A. Siddiqui
- Design and Prediction of ADME/Tox Properties of Novel Magnolol Derivatives as Anticancer Agents for NSCLC Using 3D-QSAR, Molecular Docking, MOLCAD and MM-GBSA Studies
  
  Authors: Ossama Daoui, Souad Elkhattabi and Samir Chtita
- Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease
  
  Authors: Kazuhiro Honda, Paula I. Moreira, Quan Liu, Sandra L. Siedlak, Xiongwei Zhu, Mark A Smith and George Perry
- Identifying Protein Binding Sites and Optimal Ligands
  
  Authors: Albert Beuscher, Arthur J. Olson and David S. Goodsell
- Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part I: Amides and Ureas
  
  Authors: B. Crescenzi, M. Poma, J. M. Ontoria, A. Marchetti, E. Nizi, V. G. Matassa and C. Gardelli
- Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part II: Sulfonamides
  
  Authors: S. Ponzi, C. Giuliano, M. Donghi, M. Poma, V. G. Matassa and I. Stansfield
- Selection of a Catalytically Active Enzyme In Vivo Via Phage Display of its Product
  
  Authors: T. Taki, S. Fujita and K. Taira
- A Comprehensive Review of the Advancement in Omic Technologies in the Field of Drug Discovery and Development
  
  Authors: Mridula Chauhan, Shivansh Kumar, Arpon Biswas, Mukesh Kumar, Sarvesh Kumar Verma, Anjali Mishra, Vaishali Singh, Amol Chhatrapati Bisen, Sristi Agrawal, Abhijit Deb Choudhury, Ramakrishna Rayiti and Rabi Sankar Bhatta
More Less

Letters in Drug Design & Discovery - Volume 21, Issue 15, 2024

Volume 21, Issue 15, 2024

In silico Exploration of the Therapeutic Potential of Alkaloids as Anti-infective Agents

Volumes & issues

Volume 21 (2024)

Volume 20 (2023)

Volume 19 (2022)

Volume 18 (2021)

Volume 17 (2020)

Volume 16 (2019)

Volume 15 (2018)

Volume 14 (2017)

Volume 13 (2016)

Volume 12 (2015)

Volume 11 (2014)

Volume 10 (2013)

Volume 9 (2012)

Volume 8 (2011)

Volume 7 (2010)

Volume 6 (2009)

Volume 5 (2008)

Volume 4 (2007)

Volume 3 (2006)

Volume 2 (2005)

Volume 1 (2004)

Most Read This Month

Most Cited Most Cited RSS feed

Discovery, Structural Determination and Anticancer Activities of Lactucinlike Guaianolides

Thermodynamic Aspects of Cancer: Possible Role of Negative Entropy in Tumor Growth, its Relation to Kinetic and Genetic Resistance

Immunomodulatory Properties of Synthetic Imidazolone Derivatives

Design and Prediction of ADME/Tox Properties of Novel Magnolol Derivatives as Anticancer Agents for NSCLC Using 3D-QSAR, Molecular Docking, MOLCAD and MM-GBSA Studies

Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease

Identifying Protein Binding Sites and Optimal Ligands

Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part I: Amides and Ureas

Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part II: Sulfonamides

Selection of a Catalytically Active Enzyme In Vivo Via Phage Display of its Product

A Comprehensive Review of the Advancement in Omic Technologies in the Field of Drug Discovery and Development